
Christopher Gerard Bunick MD
Acne & Rosacea, Dermatologic Surgery, Pediatric Dermatology
Assistant Professor of Dermatology
Join to view full profile
20 York St# T-209New Haven, CT 06510
Phone+1 203-688-2259
Fax+1 203-688-5599
Dr. Bunick is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Christopher Bunick is a dermatologist in New Haven, CT and is affiliated with Yale-New Haven Hospital. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 9 years. He specializes in acne & rosacea, dermatologic surgery, and pediatric dermatology and is experienced in general dermatology, dermatologic surgery, pediatric dermatology, mohs micrographic surgery, and computational biology.
Education & Training
Yale-New Haven Medical CenterResidency, Dermatology, 2009 - 2012
Yale-New Haven Medical CenterResidency, Internal Medicine, 2008 - 2009
Vanderbilt University School of MedicineClass of 2008
Vanderbilt University School of MedicinePh.D., Biochemistry, 2006
Vanderbilt UniversityB.S., Molecular Biology & Mathematics, 2000
Certifications & Licensure
FL State Medical License 2022 - Present
CT State Medical License 2012 - 2026
TN State Medical License 2016 - 2026
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- 23rd World Congress of Dermatology Rising Star Scholarship 2015
Publications & Presentations
PubMed
- Long-term benefits of upadacitinib for Atopic Dermatitis: deep responses in patient-reported outcomes over 140 weeks from the Measure Up 1 and Measure Up 2 clinical tr...Eric L Simpson, Vimal H Prajapati, Christopher G Bunick, Raj Chovatiya, Linda F Stein Gold
The Journal of Dermatological Treatment. 2026-12-01 - Physicochemical properties of phosphodiesterase-4 inhibitor orismilast and implications for new inhibitor design.Jimin Wang, Victor S Batista, Christopher G Bunick
The Journal of Investigative Dermatology. 2026-08-15 - Delgocitinib cream for the treatment of refractory vulvar lichen sclerosus.Paige L McKenzie, Ana Preda-Naumescu, Christopher G Bunick
JAAD Case Reports. 2026-08-01
Journal Articles
- X-ray crystal structure of the keratin 1-keratin 10 heterodimer reveals a molecular basis for associated keratinopathiesBunick, CG, Invest Dermatol, 1/1/2015
- Crystal structure of human profilaggrin S100 domain and identification of target proteins annexin II, stratifin, and hsp27Bunick CG, Presland, RB, Lawrence, OT, Pearton, DJ, Milstone, LM, Steitz, TA, J Invest Dermatol, 1/1/2015
- Genomic landscape of cutaneous T cell lymphomaChoi J, Goh G, Walradt T, Hong BS, Bunick CG, Chen K, Bjornson RD, Maman Y, Wang T, Tordoff J, Carlson K, Overton JD, Liu KJ, Lewis JM, Devine L, Barbarotta L, Foss FM..., Nature Genetics, 1/1/2015
Books/Book Chapters
Lectures
- Using x-ray crystallography to correlate protein structure with function in human skin diseasesAtlanta, GA - 1/6/2015
- X-ray crystal structure of the keratin 1-keratin 10 heterodimer reveals a molecular basis for associated keratinopathiesVancouver, Canada - 1/1/2015
- Molecular Dermatology: understanding the structure and function of skin barrier proteins using x-ray crystallography1/1/2014
Authored Content
- Breaking the Itch-Scratch CycleJune 2023
Press Mentions
How Tetracyclines Work: New Study Redefines Mechanism-Of-ActionMay 19th, 2026
Connecticut Magazine Names 24 Yale Dermatologists “Top Doctors”May 7th, 2026
2025 Drug Approvals: Despite FDA Tumult and Macro Uncertainty, Biopharma Scored with 55 New ProductsJanuary 5th, 2026
Grant Support
- Molecular function of an intermediate filament assembly mechanism in epidermal protein complexes and cell migrationYALE UNIVERSITY2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









